SyncoZymes

nhau

Nhau dzakanaka: Shangke Bio yave kuzivikanwa seyepamusoro-tekinoroji yebudiriro yekushandura chirongwa

Musi wa5 Ndira 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. yakapihwa "(S) -1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.

Sebhizimusi renyika repamusoro-soro, Suntech Biotech inogara ichitora biotechnology kutungamira kusimukira kweindasitiri yemakemikari nemishonga, uye inounza girinhi uye hutano kuvanhu sechinangwa chayo.Kuwedzera bhizinesi nenzira dzakawanda, kushandira pamwe nezvikoro zvinozivikanwa uye mabhizinesi epamba nekune dzimwe nyika, inogara ichivandudza budiriro yaro, kukwidziridza kurongeka kwemukati kwebhizinesi, uye kuve nani uye kusimba.

kubudirira kwepamusoro-soro

Zita rechirongwa: (S) -1-tert-Butoxycarbonyl-3-hydroxypiperidine
Nhamba yechinhu: 202010694
Nhamba yechinhu: B
Kunyangwe paine zvakabudirira mumunda wepamusoro-soro nekodzero dzakazvimirira dzepfuma: Hongu

Kushandisa: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) inokosha chiral iri pakati pekugadzirisa kwe ibrutinib APIs.Ibrutinib mushonga mutsva weanticancer wakanangana neB-cell malignancies iyo yakabvumidzwa pasi pemvumo yakakurumidza neUS Food and Drug Administration (FDA) muna Mbudzi 13, 2013 yekurapa lymphoma.

Tsanangudzo yekushandura kwepamusoro-tech kubudirira
Shanduko yekubudirira kwepamusoro-tekinoroji inoreva maitiro ayo mabhizinesi anoita kugadzirwa kwepamusoro-tekinoroji uye kushanda.Nyika inotsigira mabhizinesi kuita shanduko yesainzi uye tekinoroji kubudirira kuburikidza nekutsvaga kwakazvimirira nekusimudzira, kupa marezinesi, kutora migove nemutengo, uye kushandira pamwe nemaindasitiri, mayunivhesiti uye masangano ekutsvagisa.Kune epamusoro-tekinoroji yebudiriro mapurojekiti akaongororwa uye kutaurwa nebhizinesi, maererano nekupedzwa kweakazara zviratidzo zvehupfumi uye hunhu hweiyo purojekiti kodzero yezvivakwa zvehungwaru, dhigirii rekuvandudza, nezvimwewo, mari yayo yeR&D ine chekuita neprojekiti. -inoenderana nekodzero dzepfuma yehungwaru, zvitupa zvekugadzira patent, kana avo vari kupinda muchikamu chebvunzo.Chitupa cherukudzo chakapihwa bhizinesi mushure mekuongorora kwakasimba uye kunyatsoferefetwa kwemusika, senge zvinhu zvehumbowo zvekugadzira patent application, utility modhi patent chitupa, software yekunyoresa copyright setifiketi, yakabatanidzwa yedunhu dhizaini dhizaini retifiketi, nezvimwe.

Profile yekambani
Shangke Biomedical (Shanghai) Co., Ltd. yakavambwa muna 2008 uye iri muInternational Medical Park, nzvimbo yekumaodzanyemba kweZhangjiang Hi-Tech Park, Pudong, Shanghai.Iri idivi rakazara reZhejiang Shangke Biomedical Co., Ltd. Shangke Bio yakazvipira kutsvaga nekusimudzira nzvimbo yemishonga yakasvibira yakanyanya, inotungamira kusimudzirwa kweindasitiri yemishonga yemishonga ine green biotechnology, uye inopa hutsva. zvigadzirwa uye zvemhando yepamusoro masevhisi eindasitiri yemishonga.Iri ibhizimusi repamusoro-tekinoroji muShanghai uye zvakare iShanghai yepamusoro-tech bhizinesi "Yakasarudzika, yakanatswa, yakakosha uye nyowani" bhizinesi.

Bhizinesi guru reSuntech rinosanganisira: kuvandudza uye kushandiswa kwema enzymes ehupenyu, kusimudzira uye kugadzirwa kwemishonga yepakati, APIs uye inoshanda makemikari.Zvigadzirwa zvikuru zvekambani iyi zvigadzirwa zvecoenzyme, zvinosanganisira NMN, NAD, NADP, NADH, NADPH, biological enzymes, mishonga mbishi zvinhu uye zvepakati.Vatengi vekambani iyi uye vanodyidzana navo pasi rese, uye yakaumba hukama hwepedyo hwekudyidzana nemakambani mazhinji emishonga muNorth America, Europe, India neChina.


Nguva yekutumira: Jan-15-2021